NOC
43
8
DLTR
54
-5
VTR
41
-3
FOXA
74
5
SLG
56
-6
MCD
39
-3
VLO
60
5
R
80
3
CAT
57
2
C
84
3
CVS
48
-5
SWKS
51
-5
CSX
39
3
PFE
26
-3
MTCH
46
6
UNH
9
-5
EOG
51
2
CTSH
59
-3
MOS
62
2
CCI
15
-2
NOC
43
8
DLTR
54
-5
VTR
41
-3
FOXA
74
5
SLG
56
-6
MCD
39
-3
VLO
60
5
R
80
3
CAT
57
2
C
84
3
CVS
48
-5
SWKS
51
-5
CSX
39
3
PFE
26
-3
MTCH
46
6
UNH
9
-5
EOG
51
2
CTSH
59
-3
MOS
62
2
CCI
15
-2
Financhill
Back

scPharmaceuticals Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
22

SCPH
scPharmaceuticals

Last Price:
$2.27
Seasonality Move:
-3.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCPH is experiencing selling pressure, which indicates risk of future bearish movement.

scPharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.44 Sell
20-day SMA: 2.5 Sell
50-day SMA: 2.67 Sell
200-day SMA: 3.73 Sell
8-day EMA: 2.43 Sell
20-day EMA: 2.48 Sell
50-day EMA: 2.67 Sell
200-day EMA: 3.55 Sell

scPharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 42.24 Sell
Chaikin Money Flow: -256169 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.29 - 2.61) Sell
Bollinger Bands (100): (2.59 - 3.45) Sell

scPharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for scPharmaceuticals Stock

Is scPharmaceuticals Stock a Buy?

  • scPharmaceuticals share price is 2.32 while SCPH 8-day simple moving average is 2.44, which is a Sell signal.
  • The stock price of SCPH is 2.32 while scPharmaceuticals 20-day SMA is 2.50, which makes it a Sell.
  • scPharmaceuticals 50-day simple moving average is 2.67 while SCPH share price is 2.32, making it a Sell technically.
  • SCPH stock price is 2.32 and scPharmaceuticals 200-day simple moving average is 3.73, creating a Sell signal.

SCPH Technical Analysis vs Fundamental Analysis

Sell
22
scPharmaceuticals (SCPH) is a Sell

Is scPharmaceuticals a Buy or a Sell?

  • scPharmaceuticals stock is rated a Sell
    The current scPharmaceuticals [SCPH] share price is $2.32. The Score for SCPH is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.

scPharmaceuticals Stock Info

Market Cap:
116.7M
Price in USD:
2.32
Share Volume:
399.6K

scPharmaceuticals 52-Week Range

52-Week High:
5.65
52-Week Low:
1.94
Sell
22
scPharmaceuticals (SCPH) is a Sell

scPharmaceuticals Share Price Forecast

Is scPharmaceuticals Stock a Buy?

  • scPharmaceuticals share price is 2.32 while SCPH 8-day exponential moving average is 2.43, which is a Sell signal.
  • The stock price of SCPH is 2.32 while scPharmaceuticals 20-day EMA is 2.48, which makes it a Sell.
  • scPharmaceuticals 50-day exponential moving average is 2.67 while SCPH share price is 2.32, making it a Sell technically.
  • SCPH stock price is 2.32 and scPharmaceuticals 200-day simple moving average is 3.55, creating a Sell signal.

Fundamental Analysis of scPharmaceuticals

Is scPharmaceuticals a good investment?

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.83 per share, and an increase next year of $0.66 per share.

Technical Analysis of scPharmaceuticals

Should I short scPharmaceuticals stock?

* scPharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.